CoChat

Prevalence and patterns of substance use in West Africa: A systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index; 22 of the 43 sources its claims cite were checked for support.

Abstract

A systematic review and meta-analysis of substance use in West Africa across 22 studies (N=43,145) from 2000 to 2024 revealed pooled prevalence rates of alcohol (44%), tramadol (30%), kolanut (39%), codeine (11%), and cannabis (6%), demonstrating the heavy dual burden of alcohol and pharmaceutical opioids among youth.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis of 22 studies (43,145 participants) found substance use in West Africa is widespread, with pooled prevalences of alcohol 44%, tramadol 30%, kolanut 39%, codeine 11%, and cannabis 6%. Heterogeneity was very high (I² = 98–99%), but leave-one-out sensitivity analysis indicated the pooled estimates were robust.

Key findings

  • Pooled prevalence estimates: alcohol 44% (95% CI 34–54%), cannabis 6% (3–10%), tramadol 30% (17–49%), codeine 11%, kolanut 39% (25–55); also cigarette 10% (3–31%), cocaine 2% (1–7%), heroin 2% (0–10%), marijuana 6% (2–19%), sedatives 13% (7–23%), and tobacco 9% (5–16%).
  • Alcohol was the most frequently abused substance; cannabis/marijuana was the most frequently reported illegal drug; tramadol and codeine showed notable prescription opioid misuse.
  • Factors reported across studies included peer influence, family/parental supervision, availability of substances, socioeconomic conditions, demographic characteristics (younger age, male sex), religiosity, and mental health/chronic pain.
  • Quality assessment: 21/22 studies (95%) had low risk of bias, 1 had moderate risk, and none had high risk; leave-one-out sensitivity analysis showed no single study significantly altered overall prevalence.

Methods

  • PRISMA-guided systematic review and meta-analysis (PROSPERO CRD42024563715); searched PubMed, Web of Science, CINAHL, Scopus, Google Scholar, and citation sources from January 2000 to June 2024.
  • Included 22 observational studies (21 cross-sectional, 1 case-control) with 43,145 participants; most were from Nigeria (18 studies), Ghana (3), and one multi-country Sub-Saharan Africa study.
  • Random-effects meta-analysis using R 4.3.3 (`meta`, `metafor`) for substances with at least three studies; heterogeneity assessed with Cochrane’s Q and I²; leave-one-out sensitivity analysis and funnel plots for publication bias.

Limitations

  • Stated: geographic concentration in Nigeria and Ghana limits generalizability to broader West Africa; high heterogeneity (I² = 98–99%) may reflect differences in study design, populations, and contexts; variability in study tools/questionnaires may contribute to heterogeneity.
  • Stated: reliance on cross-sectional data limits assessment of changes over time and causality; underreporting of less-studied or newly emerging substances may give an incomplete picture.
  • Evident from the text: many included studies focused on student populations (11/22, 50%), with only two on internally displaced persons and one on pregnant women, so findings may not represent all West African subgroups.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pgph.0004019

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Study Flowchart showing the flow of studies from retrieval to the final included studies.
Fig 1 Study Flowchart showing the flow of studies from retrieval to the final included studies.CC BY · PubMed Central
Fig 2 Pooled prevalence of alcohol use in West Africa.
Fig 2 Pooled prevalence of alcohol use in West Africa.CC BY · PubMed Central
Fig 3 Pooled prevalence of cannabis use in West Africa.
Fig 3 Pooled prevalence of cannabis use in West Africa.CC BY · PubMed Central
Fig 4 Pooled prevalence of cigarette use in West Africa.
Fig 4 Pooled prevalence of cigarette use in West Africa.CC BY · PubMed Central
Fig 5 Pooled prevalence of cocaine use in West Africa.
Fig 5 Pooled prevalence of cocaine use in West Africa.CC BY · PubMed Central
Fig 6 Pooled prevalence of tramadol use in West Africa.
Fig 6 Pooled prevalence of tramadol use in West Africa.CC BY · PubMed Central
Fig 7 Pooled prevalence of codeine use in West Africa.
Fig 7 Pooled prevalence of codeine use in West Africa.CC BY · PubMed Central
Fig 8 Pooled prevalence of heroin use in West Africa.
Fig 8 Pooled prevalence of heroin use in West Africa.CC BY · PubMed Central
Fig 9 Pooled prevalence of kolanut use in West Africa.
Fig 9 Pooled prevalence of kolanut use in West Africa.CC BY · PubMed Central
Fig 10 Pooled prevalence of marijuana use in West Africa.
Fig 10 Pooled prevalence of marijuana use in West Africa.CC BY · PubMed Central
Fig 11 Pooled prevalence of sedatives use in West Africa.
Fig 11 Pooled prevalence of sedatives use in West Africa.CC BY · PubMed Central
Fig 12 Pooled prevalence of tobacco use in West Africa.
Fig 12 Pooled prevalence of tobacco use in West Africa.CC BY · PubMed Central

Verification

Claims the paper makes

11 Valid · 4 Not valid · 10 Not checked · 88 Own results and interpretations

52 more claims · 3 with their cited sources checked

Create a free account to see all 113 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 41
  • It may state two separate claims as one. 27
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 73 references

Research works printed but not linked: 3

  1. Health (UK) NCC for M. INTRODUCTION TO DRUG MISUSE. In: Drug Misuse: Psychosocial Interventions (Internet). British Psychological Society (UK); 2008 (cited 2024 Aug 11). Available from: https://www.ncbi.nlm.nih.gov/books/NBK53217/
  2. JB Asare, 2013, Treatment Policy for Substance Dependence in West Africa: WACD Background Paper No. 8, West Afr Comm Drug
  3. K Farzam, 2024, Stimulants. In: StatPearls (Internet)

Cited by

Metadata

Authors
Emmanuel, G. O., Akinsolu, F. T., Abodunrin, O. R., & Ezechi, O. C.
Affiliations
Nigerian Institute of Medical Research (NG)
Corresponding author
Akinsolu, Folahanmi Tomiwa
Venue
PLOS Global Public Health
Published
2024-12-31
Volume
4
Issue
12
Pages
e0004019
ISSN
2767-3375 (ISSN-L)
OpenAlex
W4405941019
Cited by
24
References
70
Citations by year
2026: 19 · 2025: 5
FWCI
1.58
Type
journal article
Language
en
Open access
Locations
  • PLOS Global Public Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Youth, Drugs, and Violence
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
substance use prevalence, alcohol consumption, cannabis use, West Africa, peer influence, socioeconomic factors, substance use risk factors, substance use prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.